SC to examine drug pricing policy
The Supreme Court is set to examine the National Pharmaceutical Pricing Policy that has finally been framed.
But coming under the back drop of a PIL moved by All Indian Drug Action net work in 2003 that prices of just 78 drugs were under control and the rest were arbitrarily priced questions loom about the new policy's efficacy.
Will it solve the problems faced by the 20 billion dollar pharmaceutical industry in India as well as the consumers?
But coming under the back drop of a PIL moved by All Indian Drug Action net work in 2003 that prices of just 78 drugs were under control and the rest were arbitrarily priced questions loom about the new policy's efficacy.
Will it solve the problems faced by the 20 billion dollar pharmaceutical industry in India as well as the consumers?
Category
ЁЯЧЮ
News